CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Senseonics Holdings, Inc. - SENS CFD

0.6573
1.15%
Market Trading Hours* (UTC) Open now
Closes on Tuesday at 20:00

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.0056
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023485 %
Charges from full value of position ($-4.46)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023485%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001262 %
Charges from full value of position ($0.24)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001262%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 0.6498
Open 0.6615
1-Year Change 24.95%
Day's Range 0.6523 - 0.6771
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 31, 2025 0.6498 0.0072 1.12% 0.6426 0.6751 0.6248
Mar 28, 2025 0.6734 -0.0257 -3.68% 0.6991 0.7064 0.6691
Mar 27, 2025 0.6945 -0.0018 -0.26% 0.6963 0.7122 0.6714
Mar 26, 2025 0.7191 -0.0221 -2.98% 0.7412 0.7442 0.6922
Mar 25, 2025 0.7440 -0.0051 -0.68% 0.7491 0.7541 0.7196
Mar 24, 2025 0.7459 0.0015 0.20% 0.7444 0.7760 0.7388
Mar 21, 2025 0.7218 0.0155 2.19% 0.7063 0.7524 0.6891
Mar 20, 2025 0.7121 0.0611 9.39% 0.6510 0.7265 0.6438
Mar 19, 2025 0.6621 0.0604 10.04% 0.6017 0.6731 0.5933
Mar 18, 2025 0.5904 -0.0263 -4.26% 0.6167 0.6167 0.5679
Mar 17, 2025 0.6048 0.0081 1.36% 0.5967 0.6305 0.5891
Mar 14, 2025 0.5890 0.0198 3.48% 0.5692 0.6148 0.5691
Mar 13, 2025 0.5691 -0.0506 -8.17% 0.6197 0.6197 0.5591
Mar 12, 2025 0.6141 -0.0050 -0.81% 0.6191 0.6754 0.6091
Mar 11, 2025 0.5944 0.0140 2.41% 0.5804 0.6093 0.5700
Mar 10, 2025 0.5836 -0.0331 -5.37% 0.6167 0.6210 0.5696
Mar 7, 2025 0.6344 0.0262 4.31% 0.6082 0.6470 0.5591
Mar 6, 2025 0.6091 -0.0623 -9.28% 0.6714 0.6714 0.5713
Mar 5, 2025 0.6875 -0.0016 -0.23% 0.6891 0.7327 0.6540
Mar 4, 2025 0.7156 0.0286 4.16% 0.6870 0.7513 0.6191

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Senseonics Holdings, Inc. Company profile

Senseonics Holdings is a medical technology company that develops and manufactures continuous glucose monitoring (CGM) systems, specialising in long-term, implantable CGM systems for diabetes patients. It was founded in 1996 and trades on the New York Stock Exchange (NYSE) under the ticker SENS.

Headquartered in Maryland, US, the company had its initial public offering (IPO) in 2016, with an underwritten public offering of 15,800,000 shares of its common stock at $2.85 a share. Leerink Partners LLC and Canaccord Genuity acted as joint book-running managers for the offering, with Raymond James & Associates as lead manager and BTIG LLC as co-manager.

In February 2022, Senseonics’ Eversense E3 Continuous Glucose Monitoring System, touted as the first and only such CGM system, was approved for use for up to six months by the US Food and Drug Administration (FDA). The technology was reported to be available to patients in the US by the second quarter of 2022 through Senseonics’ global commercial partner, Ascensia Diabetes Care

The company’s partnership with Ascencia began in August 2020, when the pair announced a collaboration and commercialisation agreement that made Ascencia the sole distributor of Senseonics’ Eversense CGM systems worldwide. At that same time, Seseonics announced a financing agreement with Ascencia’s parent company, Masters Special Situations. The two agreements collectively made for $80m of debt and equity capital.

Industry: Medical Equipment, Supplies & Distribution (NEC)

20451 Seneca Meadows Pkwy
GERMANTOWN
MARYLAND 20876-7005
US

People also watch

ETH/USD

1,923.14 Price
+5.470% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

XRP/USD

2.15 Price
+2.590% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01073

US100

19,383.10 Price
+0.640% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

85,325.15 Price
+3.410% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 710,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading